
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16175524
[patent_doc_number] => 20200222492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => Method of Reducing Injury to Mammalian Cells
[patent_app_type] => utility
[patent_app_number] => 16/578318
[patent_app_country] => US
[patent_app_date] => 2019-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16578318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/578318 | Method of Reducing Injury to Mammalian Cells | Sep 20, 2019 | Abandoned |
Array
(
[id] => 17415213
[patent_doc_number] => 20220050117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => GLX-DERIVED MOLECULE DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/274741
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274741 | GLX-DERIVED MOLECULE DETECTION | Sep 11, 2019 | Abandoned |
Array
(
[id] => 20527291
[patent_doc_number] => 12545715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Refining method of ophthalmic aflibercept
[patent_app_type] => utility
[patent_app_number] => 17/625528
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2982
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625528 | Refining method of ophthalmic aflibercept | Sep 8, 2019 | Issued |
Array
(
[id] => 15831921
[patent_doc_number] => 20200131242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHODS OF TREATMENT WITH LONG-ACTING HORMONE
[patent_app_type] => utility
[patent_app_number] => 16/511881
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511881
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511881 | METHODS OF TREATMENT WITH LONG-ACTING HORMONE | Jul 14, 2019 | Abandoned |
Array
(
[id] => 17083400
[patent_doc_number] => 20210278406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA
[patent_app_type] => utility
[patent_app_number] => 17/259815
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259815 | ISOLATION OF CIRCULATING CELLS OF FETAL ORIGIN USING RECOMBINANT MALARIA PROTEIN VAR2CSA | Jul 11, 2019 | Abandoned |
Array
(
[id] => 15895311
[patent_doc_number] => 20200147174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/452459
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/452459 | METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH | Jun 24, 2019 | Abandoned |
Array
(
[id] => 14960737
[patent_doc_number] => 20190307846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
[patent_app_type] => utility
[patent_app_number] => 16/452457
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/452457 | METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH | Jun 24, 2019 | Abandoned |
Array
(
[id] => 17096911
[patent_doc_number] => 20210284702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => FUSION PROTEINS COMPRISING PROGRANULIN
[patent_app_type] => utility
[patent_app_number] => 17/253391
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253391 | FUSION PROTEINS COMPRISING PROGRANULIN | Jun 17, 2019 | Abandoned |
Array
(
[id] => 17564424
[patent_doc_number] => 20220128573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/430490
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430490 | BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF | May 29, 2019 | Abandoned |
Array
(
[id] => 16627508
[patent_doc_number] => 20210046161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => SKIN OINTMENT FOR TREATING LABIA MINORA SKIN
[patent_app_type] => utility
[patent_app_number] => 17/051165
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051165 | SKIN OINTMENT FOR TREATING LABIA MINORA SKIN | May 20, 2019 | Abandoned |
Array
(
[id] => 16720106
[patent_doc_number] => 20210087253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => APPLICATION OF TACI-FC FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDERS AND MULTIPLE SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 16/760413
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760413 | APPLICATION OF TACI-FC FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDERS AND MULTIPLE SCLEROSIS | May 14, 2019 | Abandoned |
Array
(
[id] => 15711223
[patent_doc_number] => 20200102377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => TREATING CLUSTER HEADACHE
[patent_app_type] => utility
[patent_app_number] => 16/412992
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412992 | TREATING CLUSTER HEADACHE | May 14, 2019 | Abandoned |
Array
(
[id] => 16748735
[patent_doc_number] => 20210100744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => BIORESPONSIVE HYDROGEL MATRIXES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/054609
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054609 | BIORESPONSIVE HYDROGEL MATRIXES AND METHODS OF USE | May 12, 2019 | Abandoned |
Array
(
[id] => 15041387
[patent_doc_number] => 20190331698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => MOLECULAR MARKER AND KIT FOR EARLY DIAGNOSIS AND PREDICTION OF SEPSIS ACUTE KIDNEY INJURY AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/405992
[patent_app_country] => US
[patent_app_date] => 2019-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16405992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/405992 | MOLECULAR MARKER AND KIT FOR EARLY DIAGNOSIS AND PREDICTION OF SEPSIS ACUTE KIDNEY INJURY AND APPLICATION THEREOF | May 6, 2019 | Abandoned |
Array
(
[id] => 15035651
[patent_doc_number] => 20190328830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Compositions and Methods for Treatment of Social Dysfunction Disorders
[patent_app_type] => utility
[patent_app_number] => 16/398744
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398744 | Oxytocin and opioid antagonists for treatment of social dysfunction disorder | Apr 29, 2019 | Issued |
Array
(
[id] => 16620041
[patent_doc_number] => 20210038694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COMPOSITION FOR CONTROLLED OVARIAN STIMULATION
[patent_app_type] => utility
[patent_app_number] => 17/044220
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044220 | COMPOSITION FOR CONTROLLED OVARIAN STIMULATION | Apr 24, 2019 | Abandoned |
Array
(
[id] => 15590453
[patent_doc_number] => 20200071761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => BIOMARKER PAIRS FOR PREDICTING PRETERM BIRTH
[patent_app_type] => utility
[patent_app_number] => 16/380938
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/380938 | Biomarker pairs for predicting preterm birth | Apr 9, 2019 | Issued |
Array
(
[id] => 14627415
[patent_doc_number] => 20190227075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => SECRETOME PROFILE-FACILITATED IN VITRO FERTILIZATION
[patent_app_type] => utility
[patent_app_number] => 16/375210
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/375210 | SECRETOME PROFILE-FACILITATED IN VITRO FERTILIZATION | Apr 3, 2019 | Abandoned |
Array
(
[id] => 16841721
[patent_doc_number] => 11013780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Methods of treating female infertility
[patent_app_type] => utility
[patent_app_number] => 16/369847
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 25
[patent_no_of_words] => 50975
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16369847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/369847 | Methods of treating female infertility | Mar 28, 2019 | Issued |
Array
(
[id] => 14529933
[patent_doc_number] => 20190200587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION
[patent_app_type] => utility
[patent_app_number] => 16/360285
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360285 | SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION | Mar 20, 2019 | Abandoned |